カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

不活化ポリオワクチンの世界市場2022：ヒト二倍体細胞、サル腎細胞

■ 英語タイトル：Global Inactivated Poliovirus Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22DC3834）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22DC3834
■ 発行日：2023年1月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：75
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[不活化ポリオワクチンの世界市場2022：ヒト二倍体細胞、サル腎細胞]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

世界の不活化ポリオワクチン市場レポートは、グローバル市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
Global Info Research社の最新のリサーチによると、世界の不活化ポリオワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

不活化ポリオワクチン市場はタイプとアプリケーションによって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメントは次をカバーします。
・ヒト二倍体細胞、サル腎細胞

アプリケーション別セグメントは次のように区分されます。
・公立、私立

世界の不活化ポリオワクチン市場の主要な市場プレーヤーは以下のとおりです。
・Sanofi、GSK、Serum Institute (Bilthoven Biologicals)、IMBCA

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・欧州（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南米（ブラジル、アルゼンチン、コロンビア）
・中東/アフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査資料の内容は計15章あります。
・第1章では、不活化ポリオワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な不活化ポリオワクチンメーカーの企業概要、2019年～2022年までの不活化ポリオワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な不活化ポリオワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別不活化ポリオワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの不活化ポリオワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での不活化ポリオワクチン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および不活化ポリオワクチンの産業チェーンを掲載しています。
・第13、14、15章では、不活化ポリオワクチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
– 不活化ポリオワクチンの概要
– 種類別分析（2017年vs2021年vs2028年）：ヒト二倍体細胞、サル腎細胞
– 用途別分析（2017年vs2021年vs2028年）：公立、私立
– 世界の不活化ポリオワクチン市場規模・予測
– 世界の不活化ポリオワクチン生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Sanofi、GSK、Serum Institute (Bilthoven Biologicals)、IMBCA
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：ヒト二倍体細胞、サル腎細胞
・用途別分析2017年-2028年：公立、私立
・不活化ポリオワクチンの北米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・不活化ポリオワクチンのヨーロッパ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・不活化ポリオワクチンのアジア市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・不活化ポリオワクチンの南米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・不活化ポリオワクチンの中東・アフリカ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Inactivated Poliovirus Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Inactivated Poliovirus Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Human Diploid Cell
1.2.3 Monkey Kidney Cell
1.3 Market Analysis by Application
1.3.1 Overview: Global Inactivated Poliovirus Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Public
1.3.3 Private
1.4 Global Inactivated Poliovirus Vaccine Market Size & Forecast
1.4.1 Global Inactivated Poliovirus Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Inactivated Poliovirus Vaccine Sales in Volume (2017-2028)
1.4.3 Global Inactivated Poliovirus Vaccine Price (2017-2028)
1.5 Global Inactivated Poliovirus Vaccine Production Capacity Analysis
1.5.1 Global Inactivated Poliovirus Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Inactivated Poliovirus Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Inactivated Poliovirus Vaccine Market Drivers
1.6.2 Inactivated Poliovirus Vaccine Market Restraints
1.6.3 Inactivated Poliovirus Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Inactivated Poliovirus Vaccine Product and Services
2.1.4 Sanofi Inactivated Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Inactivated Poliovirus Vaccine Product and Services
2.2.4 GSK Inactivated Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Serum Institute (Bilthoven Biologicals)
2.3.1 Serum Institute (Bilthoven Biologicals) Details
2.3.2 Serum Institute (Bilthoven Biologicals) Major Business
2.3.3 Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Product and Services
2.3.4 Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 IMBCA
2.4.1 IMBCA Details
2.4.2 IMBCA Major Business
2.4.3 IMBCA Inactivated Poliovirus Vaccine Product and Services
2.4.4 IMBCA Inactivated Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Inactivated Poliovirus Vaccine Breakdown Data by Manufacturer
3.1 Global Inactivated Poliovirus Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Inactivated Poliovirus Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Inactivated Poliovirus Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Inactivated Poliovirus Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Inactivated Poliovirus Vaccine Manufacturer Market Share in 2021
3.5 Global Inactivated Poliovirus Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Inactivated Poliovirus Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Inactivated Poliovirus Vaccine Market Size by Region
4.1.1 Global Inactivated Poliovirus Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Inactivated Poliovirus Vaccine Revenue by Region (2017-2028)
4.2 North America Inactivated Poliovirus Vaccine Revenue (2017-2028)
4.3 Europe Inactivated Poliovirus Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Inactivated Poliovirus Vaccine Revenue (2017-2028)
4.5 South America Inactivated Poliovirus Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Inactivated Poliovirus Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Inactivated Poliovirus Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Inactivated Poliovirus Vaccine Revenue by Type (2017-2028)
5.3 Global Inactivated Poliovirus Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Inactivated Poliovirus Vaccine Sales in Volume by Application (2017-2028)
6.2 Global Inactivated Poliovirus Vaccine Revenue by Application (2017-2028)
6.3 Global Inactivated Poliovirus Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Inactivated Poliovirus Vaccine Sales by Type (2017-2028)
7.2 North America Inactivated Poliovirus Vaccine Sales by Application (2017-2028)
7.3 North America Inactivated Poliovirus Vaccine Market Size by Country
7.3.1 North America Inactivated Poliovirus Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Inactivated Poliovirus Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Inactivated Poliovirus Vaccine Sales by Type (2017-2028)
8.2 Europe Inactivated Poliovirus Vaccine Sales by Application (2017-2028)
8.3 Europe Inactivated Poliovirus Vaccine Market Size by Country
8.3.1 Europe Inactivated Poliovirus Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Inactivated Poliovirus Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Inactivated Poliovirus Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Inactivated Poliovirus Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific Inactivated Poliovirus Vaccine Market Size by Region
9.3.1 Asia-Pacific Inactivated Poliovirus Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Inactivated Poliovirus Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Inactivated Poliovirus Vaccine Sales by Type (2017-2028)
10.2 South America Inactivated Poliovirus Vaccine Sales by Application (2017-2028)
10.3 South America Inactivated Poliovirus Vaccine Market Size by Country
10.3.1 South America Inactivated Poliovirus Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Inactivated Poliovirus Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Inactivated Poliovirus Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Inactivated Poliovirus Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa Inactivated Poliovirus Vaccine Market Size by Country
11.3.1 Middle East & Africa Inactivated Poliovirus Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Inactivated Poliovirus Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Inactivated Poliovirus Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Inactivated Poliovirus Vaccine
12.3 Inactivated Poliovirus Vaccine Production Process
12.4 Inactivated Poliovirus Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Inactivated Poliovirus Vaccine Typical Distributors
13.3 Inactivated Poliovirus Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Inactivated Poliovirus Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Inactivated Poliovirus Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Inactivated Poliovirus Vaccine Product and Services
Table 6. Sanofi Inactivated Poliovirus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Major Business
Table 9. GSK Inactivated Poliovirus Vaccine Product and Services
Table 10. GSK Inactivated Poliovirus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Serum Institute (Bilthoven Biologicals) Basic Information, Manufacturing Base and Competitors
Table 12. Serum Institute (Bilthoven Biologicals) Major Business
Table 13. Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Product and Services
Table 14. Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. IMBCA Basic Information, Manufacturing Base and Competitors
Table 16. IMBCA Major Business
Table 17. IMBCA Inactivated Poliovirus Vaccine Product and Services
Table 18. IMBCA Inactivated Poliovirus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Global Inactivated Poliovirus Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 20. Global Inactivated Poliovirus Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 21. Market Position of Manufacturers in Inactivated Poliovirus Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 22. Global Inactivated Poliovirus Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 23. Head Office and Inactivated Poliovirus Vaccine Production Site of Key Manufacturer
Table 24. Inactivated Poliovirus Vaccine New Entrant and Capacity Expansion Plans
Table 25. Inactivated Poliovirus Vaccine Mergers & Acquisitions in the Past Five Years
Table 26. Global Inactivated Poliovirus Vaccine Sales by Region (2017-2022) & (K Units)
Table 27. Global Inactivated Poliovirus Vaccine Sales by Region (2023-2028) & (K Units)
Table 28. Global Inactivated Poliovirus Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 29. Global Inactivated Poliovirus Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 30. Global Inactivated Poliovirus Vaccine Sales by Type (2017-2022) & (K Units)
Table 31. Global Inactivated Poliovirus Vaccine Sales by Type (2023-2028) & (K Units)
Table 32. Global Inactivated Poliovirus Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 33. Global Inactivated Poliovirus Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 34. Global Inactivated Poliovirus Vaccine Price by Type (2017-2022) & (USD/Unit)
Table 35. Global Inactivated Poliovirus Vaccine Price by Type (2023-2028) & (USD/Unit)
Table 36. Global Inactivated Poliovirus Vaccine Sales by Application (2017-2022) & (K Units)
Table 37. Global Inactivated Poliovirus Vaccine Sales by Application (2023-2028) & (K Units)
Table 38. Global Inactivated Poliovirus Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 39. Global Inactivated Poliovirus Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 40. Global Inactivated Poliovirus Vaccine Price by Application (2017-2022) & (USD/Unit)
Table 41. Global Inactivated Poliovirus Vaccine Price by Application (2023-2028) & (USD/Unit)
Table 42. North America Inactivated Poliovirus Vaccine Sales by Country (2017-2022) & (K Units)
Table 43. North America Inactivated Poliovirus Vaccine Sales by Country (2023-2028) & (K Units)
Table 44. North America Inactivated Poliovirus Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 45. North America Inactivated Poliovirus Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 46. North America Inactivated Poliovirus Vaccine Sales by Type (2017-2022) & (K Units)
Table 47. North America Inactivated Poliovirus Vaccine Sales by Type (2023-2028) & (K Units)
Table 48. North America Inactivated Poliovirus Vaccine Sales by Application (2017-2022) & (K Units)
Table 49. North America Inactivated Poliovirus Vaccine Sales by Application (2023-2028) & (K Units)
Table 50. Europe Inactivated Poliovirus Vaccine Sales by Country (2017-2022) & (K Units)
Table 51. Europe Inactivated Poliovirus Vaccine Sales by Country (2023-2028) & (K Units)
Table 52. Europe Inactivated Poliovirus Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 53. Europe Inactivated Poliovirus Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 54. Europe Inactivated Poliovirus Vaccine Sales by Type (2017-2022) & (K Units)
Table 55. Europe Inactivated Poliovirus Vaccine Sales by Type (2023-2028) & (K Units)
Table 56. Europe Inactivated Poliovirus Vaccine Sales by Application (2017-2022) & (K Units)
Table 57. Europe Inactivated Poliovirus Vaccine Sales by Application (2023-2028) & (K Units)
Table 58. Asia-Pacific Inactivated Poliovirus Vaccine Sales by Region (2017-2022) & (K Units)
Table 59. Asia-Pacific Inactivated Poliovirus Vaccine Sales by Region (2023-2028) & (K Units)
Table 60. Asia-Pacific Inactivated Poliovirus Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 61. Asia-Pacific Inactivated Poliovirus Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 62. Asia-Pacific Inactivated Poliovirus Vaccine Sales by Type (2017-2022) & (K Units)
Table 63. Asia-Pacific Inactivated Poliovirus Vaccine Sales by Type (2023-2028) & (K Units)
Table 64. Asia-Pacific Inactivated Poliovirus Vaccine Sales by Application (2017-2022) & (K Units)
Table 65. Asia-Pacific Inactivated Poliovirus Vaccine Sales by Application (2023-2028) & (K Units)
Table 66. South America Inactivated Poliovirus Vaccine Sales by Country (2017-2022) & (K Units)
Table 67. South America Inactivated Poliovirus Vaccine Sales by Country (2023-2028) & (K Units)
Table 68. South America Inactivated Poliovirus Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 69. South America Inactivated Poliovirus Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 70. South America Inactivated Poliovirus Vaccine Sales by Type (2017-2022) & (K Units)
Table 71. South America Inactivated Poliovirus Vaccine Sales by Type (2023-2028) & (K Units)
Table 72. South America Inactivated Poliovirus Vaccine Sales by Application (2017-2022) & (K Units)
Table 73. South America Inactivated Poliovirus Vaccine Sales by Application (2023-2028) & (K Units)
Table 74. Middle East & Africa Inactivated Poliovirus Vaccine Sales by Region (2017-2022) & (K Units)
Table 75. Middle East & Africa Inactivated Poliovirus Vaccine Sales by Region (2023-2028) & (K Units)
Table 76. Middle East & Africa Inactivated Poliovirus Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 77. Middle East & Africa Inactivated Poliovirus Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 78. Middle East & Africa Inactivated Poliovirus Vaccine Sales by Type (2017-2022) & (K Units)
Table 79. Middle East & Africa Inactivated Poliovirus Vaccine Sales by Type (2023-2028) & (K Units)
Table 80. Middle East & Africa Inactivated Poliovirus Vaccine Sales by Application (2017-2022) & (K Units)
Table 81. Middle East & Africa Inactivated Poliovirus Vaccine Sales by Application (2023-2028) & (K Units)
Table 82. Inactivated Poliovirus Vaccine Raw Material
Table 83. Key Manufacturers of Inactivated Poliovirus Vaccine Raw Materials
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Inactivated Poliovirus Vaccine Typical Distributors
Table 87. Inactivated Poliovirus Vaccine Typical Customers
List of Figures
Figure 1. Inactivated Poliovirus Vaccine Picture
Figure 2. Global Inactivated Poliovirus Vaccine Revenue Market Share by Type in 2021
Figure 3. Human Diploid Cell
Figure 4. Monkey Kidney Cell
Figure 5. Global Inactivated Poliovirus Vaccine Revenue Market Share by Application in 2021
Figure 6. Public
Figure 7. Private
Figure 8. Global Inactivated Poliovirus Vaccine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Inactivated Poliovirus Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Inactivated Poliovirus Vaccine Sales (2017-2028) & (K Units)
Figure 11. Global Inactivated Poliovirus Vaccine Price (2017-2028) & (USD/Unit)
Figure 12. Global Inactivated Poliovirus Vaccine Production Capacity (2017-2028) & (K Units)
Figure 13. Global Inactivated Poliovirus Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Inactivated Poliovirus Vaccine Market Drivers
Figure 15. Inactivated Poliovirus Vaccine Market Restraints
Figure 16. Inactivated Poliovirus Vaccine Market Trends
Figure 17. Global Inactivated Poliovirus Vaccine Sales Market Share by Manufacturer in 2021
Figure 18. Global Inactivated Poliovirus Vaccine Revenue Market Share by Manufacturer in 2021
Figure 19. Inactivated Poliovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Inactivated Poliovirus Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Inactivated Poliovirus Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Inactivated Poliovirus Vaccine Sales Market Share by Region (2017-2028)
Figure 23. Global Inactivated Poliovirus Vaccine Revenue Market Share by Region (2017-2028)
Figure 24. North America Inactivated Poliovirus Vaccine Revenue (2017-2028) & (USD Million)
Figure 25. Europe Inactivated Poliovirus Vaccine Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Inactivated Poliovirus Vaccine Revenue (2017-2028) & (USD Million)
Figure 27. South America Inactivated Poliovirus Vaccine Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Inactivated Poliovirus Vaccine Revenue (2017-2028) & (USD Million)
Figure 29. Global Inactivated Poliovirus Vaccine Sales Market Share by Type (2017-2028)
Figure 30. Global Inactivated Poliovirus Vaccine Revenue Market Share by Type (2017-2028)
Figure 31. Global Inactivated Poliovirus Vaccine Price by Type (2017-2028) & (USD/Unit)
Figure 32. Global Inactivated Poliovirus Vaccine Sales Market Share by Application (2017-2028)
Figure 33. Global Inactivated Poliovirus Vaccine Revenue Market Share by Application (2017-2028)
Figure 34. Global Inactivated Poliovirus Vaccine Price by Application (2017-2028) & (USD/Unit)
Figure 35. North America Inactivated Poliovirus Vaccine Sales Market Share by Type (2017-2028)
Figure 36. North America Inactivated Poliovirus Vaccine Sales Market Share by Application (2017-2028)
Figure 37. North America Inactivated Poliovirus Vaccine Sales Market Share by Country (2017-2028)
Figure 38. North America Inactivated Poliovirus Vaccine Revenue Market Share by Country (2017-2028)
Figure 39. United States Inactivated Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Inactivated Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Inactivated Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Inactivated Poliovirus Vaccine Sales Market Share by Type (2017-2028)
Figure 43. Europe Inactivated Poliovirus Vaccine Sales Market Share by Application (2017-2028)
Figure 44. Europe Inactivated Poliovirus Vaccine Sales Market Share by Country (2017-2028)
Figure 45. Europe Inactivated Poliovirus Vaccine Revenue Market Share by Country (2017-2028)
Figure 46. Germany Inactivated Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Inactivated Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Inactivated Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Inactivated Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Inactivated Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Inactivated Poliovirus Vaccine Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Inactivated Poliovirus Vaccine Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Inactivated Poliovirus Vaccine Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Inactivated Poliovirus Vaccine Revenue Market Share by Region (2017-2028)
Figure 55. China Inactivated Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Inactivated Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Inactivated Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Inactivated Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Inactivated Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Inactivated Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Inactivated Poliovirus Vaccine Sales Market Share by Type (2017-2028)
Figure 62. South America Inactivated Poliovirus Vaccine Sales Market Share by Application (2017-2028)
Figure 63. South America Inactivated Poliovirus Vaccine Sales Market Share by Country (2017-2028)
Figure 64. South America Inactivated Poliovirus Vaccine Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Inactivated Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Inactivated Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Inactivated Poliovirus Vaccine Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Inactivated Poliovirus Vaccine Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Inactivated Poliovirus Vaccine Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Inactivated Poliovirus Vaccine Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Inactivated Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Inactivated Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Inactivated Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Inactivated Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Inactivated Poliovirus Vaccine in 2021
Figure 76. Manufacturing Process Analysis of Inactivated Poliovirus Vaccine
Figure 77. Inactivated Poliovirus Vaccine Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ポリオワクチンの世界市場2022：不活化ポリオワクチン（IPV）、経口ポリオワクチン（OPV）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22DC3834 )"不活化ポリオワクチンの世界市場2022：ヒト二倍体細胞、サル腎細胞" (英文：Global Inactivated Poliovirus Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。